News from Children’s Oncology Group

Explore the latest news from across the Children’s Oncology Group (COG) network, including advances in pediatric cancer research, clinical trial updates, and the stories behind this work.

Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children’s Oncology Group (COG) study ARST0332

02/1/2023

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children’s Oncology Group

01/17/2023

Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy

12/1/2022

Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)

11/1/2022

Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis

06/1/2022

Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction

06/1/2022

Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children’s Oncology Group

06/1/2022

Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children’s Oncology Group Study ARST1321

06/1/2022

The effects of pazopanib on doxorubicin pharmacokinetics in children and adults with non-rhabdomyosarcoma soft tissue sarcoma: a report from Children’s Oncology Group and NRG Oncology study ARST1321

04/1/2022